Medivation (MDVN) Tops Q2 EPS by 2c, Affirms Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. SPY
7. CVS
8. UNH
9. TMUS
10. LMT

Go back to Medivation (MDVN) Tops Q2 EPS by 2c, Affirms Guidance

Medivation Reports Second Quarter 2016 Financial Results

August 9, 2016 4:10 PM EDT

SAN FRANCISCO, CA -- (Marketwired) -- 08/09/16 -- Medivation, Inc. (NASDAQ: MDVN) today reported its financial results for the quarter ended June 30, 2016 and reaffirmed full-year 2016 financial guidance.

U.S. net sales of XTANDI® (enzalutamide) capsules, as recorded by Astellas, were $330.3 million for the quarter ended June 30, 2016, an increase of $31.8 million (+11% compared to the second quarter of 2015). The year-over-year net sales growth was driven by an 18% increase in underlying demand, partially offset by a lower net selling price resulting from a higher gross-to-net rate. Ex-U.S. net sales of... More